JCT  Vol.3 No.5 , October 2012
Molecular Microbial Diagnostic in Lung Transplant Recipients
Abstract: The appearing of microbial lineages carrying multiple dangerous loci are results from the extensive use of antibiotics and has brought a huge increase in the infections-derived morbidity and mortality, which is critical in the hospital setting. Etiologic agents of these non easily tractable infections include bacteria, such as the genus Staphylococcus, but also fungi and virus. Alterations in the immune system allow these organisms to invade and affect the functionality of any tissue, organ or system of the human being. Pulmonary infection occurs as result of deficient lung systemic defence mechanisms which could be altered by medical treatments or by environmental factors. The infective agents commonly gain access to the lung by air, but also by blood or lymphatic system. Staphylococcus aureus strains that share antibiotic resistance and virulence factors represent the aetiological agent responsible of many cases of bacterial pneumonia, thoracic surgery postoperative infections, and diverse tissue infections, resulting in significant disease and morbidity in recipient patients after lung transplantation. The control and treatment of Staphylococcus infections, especially methicillin resistant strains, need for developing reliable and rapid methods of detection and characterization of these microorganisms. Nowadays, new insights into the diagnostic and epidemiology of MRSA and other pathogenic staphylococci have been developed employing molecular methods. This has meant an important advance in the diagnostic and treatment plans of such infective bacteria.
Cite this paper: S. Méndez-Álvarez, G. Pulido-Reyes, J. Donate-Correa and A. Lugo, "Molecular Microbial Diagnostic in Lung Transplant Recipients," Journal of Cancer Therapy, Vol. 3 No. 5, 2012, pp. 511-520. doi: 10.4236/jct.2012.35066.

[1]   E. M. C.Nright, D. A. Robinson, G. Randle, E. J. Feil, H. Grundmann and B. G. Spratt, “The Evolutionary History of Methicillin-Resistant Staphylococcus aureus (MRSA),” Proceedings of the National Academy of Sciences, Vol. 99, No. 11, 2002, pp. 7687-7692.doi:10.1073/pnas.122108599

[2]   A. S. Field, J. Y. Paik, D. Stark, M. R. Qiu, A. Morey, M. L. Plit, E. U. Canning and A. R. Glanville, “Myositis Due to the Microsporidian Anncaliia (Brachiola) Algerae in a Lung Transplant Recipient,” Transplant Infectious Dis- ease, Vol. 14, No. 2, 2012, pp. 169-176.doi:10.1111/j.1399-3062.2012.00724.x

[3]   N. E. Hiemann, S. Grimmer, D. Kemper, C. Knosalla and R. Hetzer, “Tuberculous Meningitis in a Lung Transplanted Patient,” Transplant Infectious Disease, Vol. 14, No. 4, 2012, pp. E19-E22.doi:10.1111/j.1399-3062.2012.00736.x

[4]   J. G. Mainz, J. Hentschel, C. Schien, N. Cramer, W. Pfister, J. F. Beck and B. Tümmler, “Sinonasal Persistence of Pseudomonas Aeruginosa after Lung Transplantation,” Journal of Cystic Fibrosis, Vol. 11, No. , 2012, pp. 158-161. doi:10.1016/j.jcf.2011.10.009

[5]   S. M. Palmer, A. P. Limaye, M. Banks, D. Gallup, J. Chapman, E. C. Lawrence, J. Dunitz, A. Milstone, J. Reynolds, G. L. Yung, K. M. Chan, R. Aris, E. Garrity, V. Valentine, J. McCall, S. C. Chow, R. D. Davis and R. Avery, “Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus after Lung Transplantation: A Randomized, Controlled Trial,” Annals Internal Medicine, Vol. 152, No. 12, 2010, pp. 761-769.

[6]   N. Singh and S. Husain, “Aspergillus Infections after Lung Transplantation: Clinical Differences in Type of Transplant and Implications for Management,” The Journal of Heart and Lung Transplantation, Vol. 22, No. 3, 2003, pp. 258-266. doi:10.1016/S1053-2498(02)00477-1

[7]   P. Tabarsi, A. Soraghi, M. Marjani, P. Zandian, P. Baghaei, K. Najafizadeh, A. Droudinia, S. A. Sarrafzadeh, P. Javanmard and D. Mansouri, “Comparison of Serum and Bronchoalveolar Lavage Galactomannan in Diagnosing Invasive Aspergillosis in Solid-Organ Transplant Recipients,” Experimental Clinical Transplantation, Vol. 10, No. 3, 2012, pp. 278-281. doi:10.6002/ect.2011.0176

[8]   E. Lindsay and Nicolle, “Infection Control Programmes to Contain Antimicrobial Resistance,” World Health Organization, Geneva, 2001. doi:10.1046/j.1468-3148.2001.00071.x

[9]   J. Arranz, A. Soriano, I. Garcia, I. García, M. T. Concepción, J. Navarro, A. Arteaga, X. Filella, P. Bravo, M. Barrera, S. Escribano, A. Jiménez, E. Moneva, J. Fernandez, A. Varona, E. Herrero and D. Dominguez, “Effect of Proinflammatory Cytokines (IL-6, TNF-Alpha, IL-1beta) on Hemodynamic Performance during Orthotopic Liver Transplantation,” Transplantation Proceedings, Vol. 35, No. 5, 2003, pp. 1884-1887.doi:10.1016/S0041-1345(03)00603-1

[10]   A. T. Braun and C. A. Merlo, “Cystic Fibrosis Lung Transplantation,” Current Opinion in Pulmonary Medicine, Vol. 17, No. 6, 2011, pp. 467-472.

[11]   D. Dhar, J. L. Dickson, M. R. Carby, H. S. Lyster, A. V. Hall and N. R. Banner, “Fungal Infection in Cardiothoracic Transplant Recipients: Outcome without Systemic Amphotericin Therapy,” Transplant International, Vol. 25, No. 7, 2012, pp. 758-764. doi:10.1111/j.1432-2277.2012.01499.x

[12]   C. López-Aguilar, E. Perez-Roth, A. Moreno, M. C. Duran, C. Casanova, A. Aguirre-Jaime, S. Mendez-Alvarez, “Association between the Presence of the Panton-Valentine Leukocidin-Encoding Gene and a Lower Rate of Survival among Hospitalized Pulmonary Patients with Staphylococcal Disease,” Journal of Clinical Microbiology, Vol. 45, No. 1, 2007, pp. 274-276.doi:10.1128/JCM.02032-06

[13]   F. S. Herrero and J. B. Olivas, “Microbiology and Risk Factors for Community-Acquired Pneumonia,” Seminars in Respiratory and Critical Care Medicine, Vol. 33, No. 3, 2012, pp. 220-231. doi:10.1055/s-0032-1315634

[14]   E. Hodson, J. Craig, G. Strippoli and A. C. Webster, “Antiviral Medications for Preventing Cytomegalovirus Disease in Solid Organ Transplant Recipients,” Cochrane Database of Systemic Reviews 16, 2008, Article ID: CD003774.

[15]   D. F. Florescu, F. Qiu, R. Vivekanandan, D. F. Mercer, A. N. Langnas and A. C. Kalil, “Risk Factors and Outcomes of Staphylococcus aureus Infections after Small Bowel and Multivisceral Transplantation,” Pediatric Infectious Disease Journal, Vol. 31, No. 1, 2012, pp. 25-29. doi:10.1097/INF.0b013e3182310fb6

[16]   S. J. Peacock, G. D. I de Silva, A. Justice, C. E. Cowland, C. G. Moore, N. P. Winearls and J. Day, “Comparison of Multilocus Sequence Typing and Pulsed-Field Gel Electrophoresis as Tools for Typing Staphylococcus aureus Isolates in a Microepidemiological Setting,” Journal of Clinical Microbiology, Vol. 40, No. , 2002, pp. 3764-3777. doi:10.1128/JCM.40.10.3764-3770.2002

[17]   R. W. Bonvillain, V. G. Valentine, G. Lombard, S. Le-Place, G. Dhillon and G. Wang, “Post-Operative Infections in Cystic Fibrosis and Non-Cystic Fibrosis Patients after Lung Transplantation,” The Journal of Heart and Lung Transplantation, Vol. 26, No. 9, 2007, pp. 890-897. doi:10.1016/j.healun.2007.07.002

[18]   J. D. Christie, L. B. Edwards, P. Aurora, F. Dobbels, R. Kirk, A. O. Rahmel, D. O. Taylor, A. Y. Kucheryavaya and M. I. Hertz, “Registry of the International Society for Heart and Lung Transplantation: Twenty-Fifth Official Adult Lung and Heart/Lung Transplantation Report,” Journal of Heart and Lung Transplantation, Vol. 27, No. 9, 2008, pp. 957-969. doi:10.1016/j.healun.2008.07.018

[19]   A. Copca-álvarez, M. A. Cabrera-Suarez, G. Pulido-Reyes, J. Alcoba-Florez, M. Morales and S. Mendez-Alvarez, “Coagulase Negative Staphylococcus Causes Catheter Associated Bacteriemia in a Patient with Esophagus Adecarcinome,” Journal of Cancer Therapy, 2012 (in press).

[20]   Laboratory of Health Care Associated Infection (LHCAI), Staphylococcus Reference Unit (SRU). Health Protection Agency from UK.

[21]   S. R. Burguete, D. J. Maselli, J. F. Fernandez and S. M. Levine, “Lung Transplant Infection,” Respirology, 2012.doi:10.1111/j.1440-1843.2012.02196.x

[22]   J. Hafkin and E. Blumberg, “Infections in Lung Trans- plantation: New Insights,” Current Opinion in Organ Transplantation, Vol. 14, No. 5, 2009, pp. 483-487.doi:10.1097/MOT.0b013e32833062f6

[23]   K. D. Sims, E. A. Blumberg, “Common Infections in the Lung Transplant Recipient,” Clinics in Chest Medicine, Vol. 32, No. 2, 2011. 327-341. doi:10.1016/j.ccm.2011.02.010

[24]   A. Humar and D. Snydman, “Cytomegalovirus in Solid Organ Transplant Recipients,” American Journal of Trans- plantation, Vol. 9, Suppl. 4, 2009, pp. S78-S86.doi:10.1111/j.1600-6143.2009.02897.x

[25]   S. Husain, “Unique Characteristics of Fungal Infections in Lung Transplant Recipients,” Clinics in Chest Medicine, Vol. 30, No. 2, 2009, pp. 307-313. doi:10.1016/j.ccm.2009.03.002

[26]   M. L. Green, W. Leisenring, D. Stachel, S. A. Pergam, B. M. Sandmaier, A. Wald, L. Corey and M. Boeckh, “Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplant,” Biology of Blood and Marrow Transplantation, 2012.doi:10.1016/j.bbmt.2012.05.015

[27]   M. Zancolli, P. Canepa, A. Ceravolo, V. Parodi, F. Ansaldi, “Determinants of Invasiveness and Ability to Cause Invasive Pneumococcal Disease, Pneumonia and Acute Otitis Media of Different Serotypes of Streptococcus pneumoniae,” Journal of Preventive Medicine and Hygiene, Vol. 52, 2011, pp. 47-54.

[28]   C. Benden, P. Aurora, L. B. Edwards, A. Y. Kucheryavaya, J. D. Christie, F. Dobbels, R. Kirk, A. O. Rahmel, J. Stehlik and M. I. Hertz, “The Registry of the International Society for Heart and Lung Transplantation: Fourteenth Pediatric Lung and Heart-Lung Transplantation Report 2011,” The Journal of Heart and Lung Transplantation, Vol. 30, No. 10, 2011, pp. 1123-1132. doi:10.1016/j.healun.2011.08.011

[29]   F. P. Silveira and S. Husain, “Fungal Infections in Lung Transplant Recipients,” Current Opinion Pulmonary Medicine, Vol. 14, No. 3, 2008, pp. 211-218. doi:10.1097/MCP.0b013e3282f9b1d1

[30]   A. M. Rivera and H. W. Boucher, “Current Concepts in Antimicrobial Therapy against Select Gram-Positive Organisms: Methicillin-Resistant Staphylococcus aureus, Penicillin-Resistant Pneumococci, and Vancomycin-Resistant Enterococci,” Mayo Clinic Proceedings, Vol. 86, No. 12, 2011, pp. 1230-1243. doi:10.4065/mcp.2011.0514

[31]   V. B. Kute, M. P. Patel, S. B. Patil, P. R. Shah, A. V. Vanikar, M. R. Gumber, H. V Patel, J. D. Shrimali and H. L. Trivedi, “Bronchiolitis Obliterans Organizing Pneumonia (BOOP) after Renal Transplantation,” International Urology and Nephrology, 2012.doi:10.1007/s11255-012-0182-4

[32]   E. Pérez-Roth, J. Alcoba-Flórez, C. López-Aguilar, B. Rivero-Pérez, I. Gutiérrez-González and S. Méndez-álvarez, “A Case of Familial Furunculosis Associated to Community-Acquired Leukocidin-Positive Methicillin-Susceptible Staphylococcus aureus ST152,” Journal of Clinical Microbiology, Vol. 48, No. 1, 2010, pp. 329-332. doi:10.1128/JCM.00622-09

[33]   J. Stepan, R. Pantucek and J. Doskar, “Molecular Diagnostics of Clinically Important Staphylococci,” Folia Mi crobiologica, Vol. 49, 2004, pp. 353-386.

[34]   A. Sole and M. Salavert, “Fungal Infections after Lung Transplantation,” Current Opinion Pulmonary Medicaine, Vol. 15, No. 3, 2009, pp. 243-253.doi:10.1097/MCP.0b013e328326f410

[35]   S. Méndez-Alvarez and E. Pérez-Roth, “Multiplex PCR in Clinical Microbiology,” Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, No. 3, 2004, pp. 183-191. doi:10.1157/13058027

[36]   E. Pérez-Roth, F. Lorenzo-Díaz, N. Batista, A. Moreno and S. Méndez-álvarez, “Tracking Methicillin-Resistant Staphylococcus aureus Clones during a 5-Year Period (1998 to 2002) in a Spanish Hospital,” Journal of Clinical Microbiology, Vol. 42, No. 10, 2004, pp. 4649-4656. doi:10.1128/JCM.42.10.4649-4656.2004

[37]   E. Pérez-Roth, F. Claverie-Martín, J. Villar and S. Méndez-Alvarez, “Multiplex PCR for Simultaneous Identification of Staphylococcus aureus and Detection of Methicillin and Mupirocin Resistance,” Journal of Clinical Microbiology, Vol. 39, No. 11, 2001, pp. 4037-4041. doi:10.1128/JCM.39.11.4037-4041.2001

[38]   E. Ramos-Trujillo, E. Pérez-Roth, S. Méndez-Alvarez and F. Claverie-Martín, “Multiplex PCR for Simultaneous Detection of Enterococcal Genes vanA and vanB and Staphylococcal Genes mecA, ileS-2 and femB,” International Microbiology, Vol. 6, No. 2, 2003, pp. 113-115. doi:10.1007/s10123-003-0118-z

[39]   J. Donate-Correa, J. Alcoba-Flórez and S. Méndez-álvarez, “New Staphylococcus aureus Genetic Cluster Associated with Infectious Osteomyelitis,” International Microbiology, Vol. 14, No. 1, 2011, pp. 33-39.

[40]   E. Pérez-Roth, S. M Kwong, J. Alcoba-Florez, N. Firth and S. Méndez-Alvarez, “Complete Nucleotide Sequence and Comparative Analysis of pPR9, a 41.7-Kilobase Conjugative Staphylococcal Multiresistance Plasmid Conferring High-Level Mupirocin Resistance,” Antimicrobial Agents and Chemotherapy, Vol. 54, No. 5, 2010, pp. 2252-2257. doi:10.1128/AAC.01074-09

[41]   E. Pérez-Roth, C.López-Aguilar, J. Alcoba-Florez and S. Méndez-Alvarez, “High-Level Mupirocin Resistance within Methicillin-Resistant Staphylococcus aureus Pandemic Lineages,” Antimicrobial Agents and Chemotherapy, Vol. 50, No. 9, 2006, pp. 3207-3211. doi:10.1128/AAC.00059-06

[42]   E. Pérez-Roth, E. Armas-González, J. Alcoba-Flórez and S. Méndez-álvarez, “PCR-Based Amplification of Heterogeneous IS257-ileS2 Junctions for Molecular Monitoring of High-Level Mupirocin Resistance in Staphylococci,” Journal of Antimicrobial Chemotherapy, Vol. 66, No. 3, 2011. doi:10.1093/jac/dkq493

[43]   E. Pérez-Roth, F. Lorenzo-Díaz and S. Méndez-Alvarez, “Establishment and Clonal Dissemination of the Methicillin-Resistant Staphylococcus aureus UK-16 Epidemic Strain in a Spanish Hospital,” Journal of Clinical Microbiology, Vol. 41, No. 11, 2003, p. 5353.doi:10.1128/JCM.41.11.5353.2003

[44]   B. Rivero-Pérez, J. Alcoba-Florez and S. Méndez-Alvarez, “Evaluation of Multiple-Locus Variable-Number Tandem-Repeat Analysis for Typing Polyclonal Hospital- and Community-Acquired Methicillin-Resistant Staphylococcus aureus Populations,” Concept Press Ltd., Long Island City, 2012(in press).

[45]   F. C. Tenover, , R. R. Vaughn, L. K. McDougal, G. E. Fosheim and J. E. McGowan Jr., “Multiple-Locus Variable-Number Tandem-Repeat Assay Analysis of Methicillin-Resistant Staphylococcus aureus Strains,” Journal of Clinical Microbiology, Vol. 45, No. 7, 2007, PP. 2215-2219. doi:10.1128/JCM.02451-06

[46]   T. Ueno, S. Toyooka, J. Soh, K. Miyoshi, S. Sugimoto, M. Yamane, T. Oto and S. Miyoshi, “Intrathoracic Irrigation with Arbekacin for Methicillin-Resistant Staphylococcus aureus Empyema Following Lung Resection,” Interactive Cardiovascular and Thoracic Surgery, Vol. 15, No. 3, 2012. doi:10.1093/icvts/ivs285

[47]   G. D. de Silva, A. Justice, A. R. Wilkinson, J. Buttery, M. Herbert, N. P. Day and S. J. Peacock, “Genetic Population Structure of Coagulase-Negative Staphylococci Associated with Carriage and Disease in Preterm Infants,” Clinical Infectious Diseases, Vol. 33, No. 9, 2001, pp. 1520-1528. doi:10.1086/323338

[48]   M. E. Kaufmann, “Pulse-Field Gel Electrophoresis,” In: N. Woodford and A. P. Johnson, Eds., Molecular Bacteriology. Protocols and Clinical Applications, Humana Press, Totowa, 1998, pp. 33-50.doi:10.1385/0-89603-498-4:33

[49]   A. Singh, R. V. Goering, S. Simjee, S. L. Foley and M. J. Zervos, “Application of Molecular Techniques to the Study of Hospital Infection,” Clinical Microbiology Re- views, Vol. 19, No. 3, 2006, pp. 512-530. doi:10.1128/CMR.00025-05

[50]   H. Al-Talib, C. Y. Yean, A. Al-Khateeb, H. Hassan, K.-K. B. Singh, K. Al-Jashamy and M. Ravichandran, “A Pentaplex PCR Assay for the Rapid Detection of Methicillin-Resistant Staphylococcus aureus and Panton-Valentine Leucocidin,” BMC Microbiology, Vol. 9, 2009, p. 113. doi:10.1186/1471-2180-9-113

[51]   A. Sabat, , J. Krzyszton-Russjan, W. Strzalka, R. Filipek, K. Kosowska, W. Hryniewicz, J. Travis and J. Potempa, “New Method for Typing Staphylococcus aureus Strains: Multiple-Locus Variable-Number Tandem-Repeat Analysis of Polymorphism and Genetic Relationships of Clinical Isolates,” Journal of Clinical Microbiology, Vol. 41, No. 4, 2003, pp. 1801-1804.doi:10.1128/JCM.41.4.1801-1804.2003

[52]   B. Rivero-Pérez, E. Pérez-Roth and S. Méndez-Alvarez, “Evaluation of Multiple-Locus Variable-Number Tandem-Repeat Analysis for Typing a Polyclonal Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Population in an Area Where Such Infections Are Endemic,” Journal of Clinical Microbiology, Vol. 48, No. 8, 2010, pp. 2991-2994. doi:10.1128/JCM.02220-09

[53]   B. Rivero-Pérez, J. Alcoba-Flórez and S. Méndez-álvarez, “Genetic Diversity of Community-Associated Methicillin-Resistant Staphylococcus aureus Isolated from Tenerife Island, Spain,” Infection, Genetics and Evolution, Vol. 12, No. 3, 2012, pp. 586-590.doi:10.1016/j.meegid.2012.02.007

[54]   M. A. Abramson and D. J. Sexton, “Nosocomial Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Primary Bacteremia: At What Costs?” Infect. Control Hosp. Epidemiol. Vol. 20, No. 6, 1999, pp. 408-411. doi:10.1086/501641

[55]   A. J. Sabat, M. A. Chlebowicz, H. Grundmann, J. P. Arends, G. Kampinga, N. E. Meessen, A. W. Friedrich, J. M. van Dijl, “Microfluidic-Chip-Based Multiple-Locus Variable-Number Tandem-Repeat Fingerprinting with New Primer Sets for Methicillin-Resistant Staphylococcus aureus,” Journal of Clinical Microbiology, Vol. 50, No. 7, 2012, pp. 2255-2262. doi:10.1128/JCM.00056-12

[56]   D. Harmsen, H. Claus, W. Witte, J. Rothganger, H. Claus, D. Turnwald and U. Vogel, “Typing of Methicillin-Resistant Staphylococcus aureus in a University Hospital Setting by Using Novel Software for spa Repeat Determination and Database Management,” Journal of Clinical Microbiology, Vol. 41, No. 12, 2003, pp. 5442-5448. doi:10.1128/JCM.41.12.5442-5448.2003

[57]   M. C. Enright, N. P. Day, C. E. Davies, S. J. Peacock and B. G. Spratt, “Multilocus Sequence Typing for Characterization of Methicillin-Resistant and Methicillin Susceptible Clones of Staphylococcus aureus,” Journal of Clinical Microbiology, Vol. 38, No. 3, 2000, pp. 1008-1015.

[58]   E. J. Feil, J. E. Cooper, H. Grundmann, D. A. Robinson, M. C. Enright, T. Berendt, S. J. Peacock, J. M. Smith, M. Murphy, B. G. Spratt, C. E. Moore and N. P. Day, “How Clonal Is Staphylococcus aureus?” Journal of Bacteriology, Vol. 185, No. 11, 2003, pp. 3307-3316. doi:10.1128/JB.185.11.3307-3316.2003

[59]   D. C. Oliveira and H. de Lencastre, “Multiplex PCR Strategy for Rapid Identification of Structural Types and Variants of the mec Element in Methicillin-Resistant Staphylococcus aureus,” Antimicrobial Agents and Chemotherapy, Vol. 46, No. 7, 2002, pp. 2155-2161. doi:10.1128/AAC.46.7.2155-2161.2002

[60]   F. C. Tenover, R. D. Arbeit and R. V. Goering, “How to Select and Interpret Molecular Strain Typing Methods for Epidemiological Studies of Bacterial Infections: A Review for Healthcare Epidemiologists. Molecular Typing Working Group of the Society for Healthcare Epidemiology of America,” Infection Control and Hospital Epidemiology, Vol. 18, No. 6, 1997, pp. 426-439.doi:10.1086/647644

[61]   F. C. Tenover, R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing and B. Swaminathan, “Interpreting Chromosomal DNA Restriction Patterns Produced by Pulsed-Field Gel Electrophoresis: Criteria for Bacterial Strain Typing,” Journal of Clinical Microbiology, Vol. 33, No. 9, 1995, pp. 2233-2239.